Eurofins Scientific Shares Under Pressure: Down 15.54% Over the Week at €58.58
Eurofins Scientific shares fell by 1.97% to €58.58 this Wednesday, April 29, 2026, in mid-afternoon trading, extending a marked downward trend. Over the past seven days, the stock has seen a decline of 15.54%, in a Paris market that is itself trending downward, with the CAC 40 dropping 0.19% during the session.
Technical Setup in Oversold Territory
At €58.58, Eurofins Scientific's share price is now below the lower Bollinger Band threshold set at €59.36, indicating a potential technical oversell signal. The stock has fallen below its support level identified at €60.76, paving the way to a zone of vulnerability before the next resistance at €69.84. The RSI stands at 39, close to the 30 threshold generally associated with oversold conditions, although it has not yet reached it. The 50-day moving average (€64.87) and the 200-day moving average (€63.86) are both significantly above the current price, confirming a short-term trend break. Over three months, the performance is at -17.05%, while the stock still posts a gain of 9.25% over one year.
A Sparse Financial Calendar Until September
The lack of immediate catalysts weighs on the stock. The next official date in the laboratory testing and analysis group's financial calendar is the publication of the 2026 half-year results, expected on September 18. Until then, investors have few operational milestones that could redirect the stock's momentum. In the healthcare sector, other comparable stocks are also in negative territory this Wednesday: Sanofi is down 0.75%, reflecting a cautious stance in the European pharmaceutical sector. Eurofins Scientific's beta of -0.08 also highlights a low historical correlation with the Paris market, making the stock's specific variations all the more visible. With a monthly volatility of 7.73, the range of movements remains high as the next financial publication approaches.
